Literature DB >> 11808211

[Therapeutic effect of cyclosporin A combined with methylprednisolone pulse therapy on hemophagocytic syndrome with the central nervous system involvement].

Katsuya Yamamoto1, Masatoshi Otake, Masaru Takayanagi.   

Abstract

Two pediatric cases of hemophagocytic syndrome (HPS) with the central nervous system (CNS) involvement are reported. Case 1, a two-month-old girl with primary hemophagocytic lymphohistiocytosis, showed high fever, skin rash and hemorrhagic diathesis followed by convulsion, impairment of consciousness and involuntary movements. Case 2, an eight-year-old boy, complained of visual hallucination in the course of measles complicated with interstitial pneumonitis. MRI of the two cases disclosed multiple T2-hyperintense areas in the CNS. Both clinical symptoms and MRI findings of these cases significantly improved in response to cyclosporin A (CsA) combined with methylprednisolone (mPSL) pulse therapy. Although the pathogenesis of CNS lesions in HPS remains to be elucidated, the etiologic role of hypercytokininemia is obviously important. Because CsA and mPSL have a potent inhibitory effect on the action of cytokines, it is rational and worthwhile to use these agents in the treatment of HPS with CNS involvement.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11808211

Source DB:  PubMed          Journal:  No To Hattatsu        ISSN: 0029-0831


  2 in total

1.  Measles and secondary hemophagocytic lymphohistiocytosis.

Authors:  Chiara Iaria; Maria Silvana Leonardi; Agata Buda; Maria Luisa Toro; Antonio Cascio
Journal:  Emerg Infect Dis       Date:  2012-09       Impact factor: 6.883

2.  A Rare Case of Measles-Associated Hemophagocytic Lymphohistiocytosis in an Infant.

Authors:  Theano Lagousi; Paraskevi Korovessi; Eleni Panagouli; Vasilis Tsagris; Stavroula Kostaridou
Journal:  Cureus       Date:  2020-05-23
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.